Denne siden ble automatisk oversatt og nøyaktigheten av oversettelsen er ikke garantert. Vennligst referer til engelsk versjon for en kildetekst.

Evaluering av et omfattende skolehelseprogram i Zambia

Evaluering av et omfattende skolehelseprogram i Zambia: en klynge-randomisert kontrollert prøvelse

I Zambia har helse og velvære til barn i alderen 5 til 14 ofte blitt oversett, noe som har ført til ulike helseutfordringer som påvirker deres utvikling og utdanning. Healthy Learners (HL)-programmet, i samarbeid med den zambiske regjeringen, har som mål å møte dette gapet ved å implementere et omfattende skolehelseprogram. Trente lærere, kjent som skolehelsearbeidere (SHWs), spiller en nøkkelrolle ved å gi helseundervisning, koordinere forebyggende behandling med lokale klinikker og føre tilsyn med et "skolehelserom" for syke elever.

Denne studien er en stor klynge-randomisert kontrollstudie i 225 skoler. Målet med denne studien er å sammenligne effekten av det omfattende skolehelseprogrammet (SHP) utviklet av HL mot to alternativer: det nåværende nivået på skolehelsetilbudet og dagens skolehelseaktiviteter forsterket med ormekur og vitamin A-koordinering av HL, med deres tekniske og økonomiske støtte for å sikre pålitelig levering av alle helseaktiviteter som er planlagt av myndighetene.

  1. Hva er effekten av programmet på helsesøkende, helse- og utdanningsresultater?
  2. Hva er de indirekte effektene av programmet på lærere og klinikker?
  3. Hva er merverdien av en slik omfattende SHP, sammenlignet med (i) optimalisert (ii) eller ufullkommen (status-quo) levering av et begrenset utvalg av skolehelseaktiviteter (f.eks. ormekur og vitamin A-tilskudd)?
  4. Hvor kostbart er den omfattende SHP, og hvilke faktorer påvirker implementeringen?
  5. Hva er de potensielle fordelene med programmet for langsiktig akkumulering av menneskelig kapital (læring, velvære osv.)?

Studieoversikt

Status

Aktiv, ikke rekrutterende

Forhold

Studietype

Intervensjonell

Registrering (Faktiske)

28700

Fase

  • Ikke aktuelt

Kontakter og plasseringer

Denne delen inneholder kontaktinformasjon for de som utfører studien, og informasjon om hvor denne studien blir utført.

Studiesteder

    • Copperbelt
      • Chingola, Copperbelt, Zambia
        • Chingola District Education Board
      • Luanshya, Copperbelt, Zambia
        • Luanshya District Education Board
      • Masaiti, Copperbelt, Zambia
        • Masaiti District Education Board
    • Luapula Province
      • Kawambwa, Luapula Province, Zambia
        • Kawambwa District Education Board
      • Mwense, Luapula Province, Zambia
        • Mwense District Education Board
      • Samfya, Luapula Province, Zambia
        • Samfya District Education Board

Deltakelseskriterier

Forskere ser etter personer som passer til en bestemt beskrivelse, kalt kvalifikasjonskriterier. Noen eksempler på disse kriteriene er en persons generelle helsetilstand eller tidligere behandlinger.

Kvalifikasjonskriterier

Alder som er kvalifisert for studier

  • Barn
  • Voksen
  • Eldre voksen

Tar imot friske frivillige

Ja

Beskrivelse

  • Skoler: kvalifisert for SHP (ikke utilgjengelig i regntiden, innen 10 km fra helsesenteret)
  • Skoleadministrator: har minst ett års erfaring fra skolen og er primær- eller nestleder skoleleder (f.eks. rektor, nestleder, seniorlærer som fungerer som økonomiansvarlig)
  • Elever: registrerte og tilstede på skolen under grunnlinjen, i klasse 1, klasse 3 eller klasse 5
  • Foreldre, primære omsorgspersoner eller foresatte til utvalgte elever. Foresatte er kvalifisert hvis de bor sammen med barnet og tar skole- og helsebeslutninger for barnet i fravær av foreldre/primær omsorgspersoner.
  • Lærere: enhver lærer ansatt ved studiekvalifiserte skoler (ikke frivillige)
  • Helseanlegg: anviste anlegg i nedslagsfeltet til studieskoler
  • Helseinstitusjonsansatte: alle ansatte som utfører OPD-konsultasjon tilstede under innsamlingsdager for innretningen

Studieplan

Denne delen gir detaljer om studieplanen, inkludert hvordan studien er utformet og hva studien måler.

Hvordan er studiet utformet?

Designdetaljer

  • Primært formål: Helsetjenesteforskning
  • Tildeling: Randomisert
  • Intervensjonsmodell: Parallell tildeling
  • Masking: Ingen (Open Label)

Våpen og intervensjoner

Deltakergruppe / Arm
Intervensjon / Behandling
Eksperimentell: Skolehelseprogram (SHP)
SHP utviklet av Healthy Learners (HL) i samarbeid med Kunnskapsdepartementet (MOE), som følger WHOs retningslinjer for skolehelseaktiviteter. HL støtter oppgradering av grunnleggende sanitæranlegg og bygging av et dedikert "helserom" på skolen; trener utvalgte lærere til å bli skolehelsearbeidere (SHWs) som gir helse- og sanitærundervisning, koordinerer ormekur og vitamin A-tilskudd på skolen, og vurderer syke elever i skolehelserommet ved hjelp av et klinisk beslutningsstøttesystem (CDSS), enten ved behandling i skole eller henvise til det lokale helsestasjonen. Ved helsestasjonen blir barn henvist av SHW prioritert av helsepersonell som ser dem innen 30 minutter etter ankomst til anlegget. Skoler oppretter også studentnettverk (et "kompis"-system) der elever overvåker hverandres fravær og koordinerer med SHWs, som deretter kan følge opp med husholdningen.

Kombinasjonsintervensjon som består av:

  • Oppgradering av sanitæranlegg og bygging av et "helserom" på skolen
  • Helselærerutdanning: 5-10 lærere per skole rekrutteres og utdannes i to uker for å bli skolehelsearbeidere (SHWs) av Healthy Learners
  • SHWs: (1) leverer utdanning om helse og gode sanitærforhold og hygiene (2) koordinerer med lokale klinikker for å levere forebyggende omsorg (f.eks. ormekur og vitamin A-tilskudd); (3) vurdere syke studenter i helserommet med et nettbrettbasert klinisk beslutningsstøttesystem (CDSS); (4) behandle syke studenter på helserommet for noen tilstander (malaria, diaré, schistosomiasis, lungebetennelse, konjunktivitt) eller (5) henvise til helseinstitusjonen for behandling; (6) overvåke fravær av elever
  • Henvisning: elever henvist av SHWs får et henvisningsskjema av SHW, som inneholder informasjon om symptomer og foreslått diagnose fra CDSS. Elevene blir prioritert i den lokale klinikken.
Andre navn:
  • SHP
Skoler implementerer regjeringens politikk om å distribuere ormemidler og vitamin A-tilskudd til elever to ganger i året. Ytterligere støtte fra Healthy Learners sikrer pålitelig levering.
Andre navn:
  • Ormekur
Aktiv komparator: Ormekur og vitamin A-tilskudd
Healthy Learners vil sørge for pålitelig levering av det nasjonale ormeprogrammet to ganger i året, i samme periode som i SHP-armen, for å sammenligne effekten av forebygging alene med hele SHP.
Skoler implementerer regjeringens politikk om å distribuere ormemidler og vitamin A-tilskudd til elever to ganger i året. Ytterligere støtte fra Healthy Learners sikrer pålitelig levering.
Andre navn:
  • Ormekur
Ingen inngripen: Status quo
Skoler skal fungere som vanlig uten andre inngrep enn de vanlige aktivitetene som er planlagt og organisert av myndighetene, som fastsatt 2006 skolehelse og ernæringspolitikk, frem til slutten av rettssaken.

Hva måler studien?

Primære resultatmål

Resultatmål
Tiltaksbeskrivelse
Tidsramme
Any healthcare utilisation
Tidsramme: Eight-week daily health-diary window, completed once per child in either term 1 (rainy season, January-March 2026; ~16-18 months after intervention start) or term 2 (cold season, May-July 2026; ~20-22 months). Data reported across both rounds.
The proportion of learners who sought formal care (any government health centre or hospital, or the school health room). Equals one if reported at least once during the health diary observation period.
Eight-week daily health-diary window, completed once per child in either term 1 (rainy season, January-March 2026; ~16-18 months after intervention start) or term 2 (cold season, May-July 2026; ~20-22 months). Data reported across both rounds.
Proportion of serious illness episodes where child sought healthcare
Tidsramme: Eight-week daily health-diary window, completed once per child in either term 1 (rainy season, January-March 2026; ~16-18 months after intervention start) or term 2 (cold season, May-July 2026; ~20-22 months). Data reported across both rounds.

The investigators will calculate this as the proportion of "serious" illness episodes for which a child seeks care, at the child level. In other words, the number of serious illness episodes with care divided by the total number of serious illness episodes, for all children with at least one serious illness episode.

A serious illness episode is one during which a child's ill-health symptoms are severe enough to require medical care, either immediately or the next day. This classification is based on WHO tools (c-IMCI and IMAI): Care is needed when (i) a child experiences any red-flag symptom (e.g. difficulty breathing, convulsions); (ii) has symptoms suggestive of certain conditions (e.g. measles, malaria); (iii) has experienced mild symptoms for a long time (coughing for 14 days, etc).

During an illness episode, a child will be considered to seek medical care if they visit (i) the health room (treatment arm) or (ii) a government clinic or hospital (any arm).

Eight-week daily health-diary window, completed once per child in either term 1 (rainy season, January-March 2026; ~16-18 months after intervention start) or term 2 (cold season, May-July 2026; ~20-22 months). Data reported across both rounds.
Panel-based attendance rate
Tidsramme: Repeated measure captured at each of five unannounced attendance spot checks: term 1 2025, term 2 2025, term 3 2025, term 1 2026, and term 2 2026 (alongside endline), approximately 4-22 months after the start of the intervention (September 2024)
The program's effect on school attendance is assessed using data collected through repeated, unannounced spot checks at each school. The primary attendance measure will be based on the sample of children enrolled in the study at baseline and confirmed to still be enrolled in their original school at the time of the visit. In this sample, the attendance rate, measured at each attendance spot check, will be the proportion of those children confirmed present in class on the day of the visit.
Repeated measure captured at each of five unannounced attendance spot checks: term 1 2025, term 2 2025, term 3 2025, term 1 2026, and term 2 2026 (alongside endline), approximately 4-22 months after the start of the intervention (September 2024)
Register-based (cross-sectional) attendance
Tidsramme: Repeated measure captured at each of four unannounced attendance spot checks: term 2 2025, term 3 2025, term 1 2026, and term 2 2026 (alongside endline), approximately 8-22 months after the start of the intervention (September 2024)
Additional measure of attendance, focusing on students in grades 1, 3, 5, and 7 at the time of the spot check. This register-based measure is defined as the proportion of children on the register who are present on the day of the spot check and confirmed by school staff as enrolled in the selected class on the visit day.
Repeated measure captured at each of four unannounced attendance spot checks: term 2 2025, term 3 2025, term 1 2026, and term 2 2026 (alongside endline), approximately 8-22 months after the start of the intervention (September 2024)

Sekundære resultatmål

Resultatmål
Tiltaksbeskrivelse
Tidsramme
Malaria prevalence (proportion of children testing positive for malaria)
Tidsramme: Single biomarker measurement at the end of the child's diary round - term 1 (~March 2026; ~18 months after intervention start) or term 2 (~July 2026; ~22 months). Data reported across both rounds.
Testing for the presence of P. falciparum, non-falciparum species, or a mixed infection. The tests are performed using a rapid diagnostic test (RDT) on the sample of children taking part in the health diaries (testing will occur at the end of the period).
Single biomarker measurement at the end of the child's diary round - term 1 (~March 2026; ~18 months after intervention start) or term 2 (~July 2026; ~22 months). Data reported across both rounds.
Proportion of children with moderate or severe anaemia
Tidsramme: Single biomarker measurement at the end of the child's diary round - term 1 (~March 2026; ~18 months after intervention start) or term 2 (~July 2026; ~22 months). Data reported across both rounds.
Haemoglobin concentration measured using a HemoCue photometer in the sample of children taking part in the health diaries (testing will occur at the end of the period). Anemia severity categories will be based on the WHO classification which depends on the age and sex of the child. Haemoglobin is first adjusted for elevation using the WHO (2024) continuous adjustment, defined in g/L as 0.0056384 times elevation in metres plus 0.0000003 times elevation squared, evaluated at each school's recorded GPS elevation and subtracted from the measured value. Moderate-to-severe anaemia is considered when adjusted haemoglobin is below 11.0 g/dL, a threshold common to all age bands represented in the sample.
Single biomarker measurement at the end of the child's diary round - term 1 (~March 2026; ~18 months after intervention start) or term 2 (~July 2026; ~22 months). Data reported across both rounds.
Proportion of children with diarrhoea
Tidsramme: Eight-week daily health-diary window, completed once per child in either term 1 (rainy season, January-March 2026; ~16-18 months after intervention start) or term 2 (cold season, May-July 2026; ~20-22 months). Data reported across both rounds.
Incidence of diarrhoea - carer report of the child experiencing three or more loose or watery stools.
Eight-week daily health-diary window, completed once per child in either term 1 (rainy season, January-March 2026; ~16-18 months after intervention start) or term 2 (cold season, May-July 2026; ~20-22 months). Data reported across both rounds.
Haematuria prevalence
Tidsramme: Endline, May-July 2026 (approximately 20-22 months after the start of the intervention, September 2024). Recall over last 7 days.
An indicator for incidence of haematuria (blood in urine) reported by the caregiver.
Endline, May-July 2026 (approximately 20-22 months after the start of the intervention, September 2024). Recall over last 7 days.
Share of diary days with any reported symptom
Tidsramme: Eight-week daily health-diary window, completed once per child in either term 1 (rainy season, January-March 2026; ~16-18 months after intervention start) or term 2 (cold season, May-July 2026; ~20-22 months). Data reported across both rounds.

The share of days on which the child was reported to have any symptom, over the eight week symptom diary recording period (0 days if no symptoms recorded).

Proportion of completed health-diary days on which the child reported one or more symptoms. Computed per child as (diary days with ≥1 reported symptom) ÷ (completed diary days). Defined for all children in the diary sub-sample; no conditioning on illness status.

Eight-week daily health-diary window, completed once per child in either term 1 (rainy season, January-March 2026; ~16-18 months after intervention start) or term 2 (cold season, May-July 2026; ~20-22 months). Data reported across both rounds.
Duration of illness episodes - all episodes
Tidsramme: Eight-week daily health-diary window, completed once per child in either term 1 (rainy season, January-March 2026; ~16-18 months after intervention start) or term 2 (cold season, May-July 2026; ~20-22 months). Data reported across both rounds.
Mean number of consecutive symptom-days per illness episode, among episodes in children who reported illness during the diary window. Estimated from a discrete-time hazard model for symptom resolution: episodes still ongoing at the end of the observation window contribute their observed (censored) days rather than being dropped; episodes already symptomatic on the first diary day are excluded (start date unobservable / left-truncated). Reported as a restricted mean over the eight-week observation window.
Eight-week daily health-diary window, completed once per child in either term 1 (rainy season, January-March 2026; ~16-18 months after intervention start) or term 2 (cold season, May-July 2026; ~20-22 months). Data reported across both rounds.
Duration of illness episodes - serious episodes
Tidsramme: Eight-week daily health-diary window, completed once per child in either term 1 (rainy season, January-March 2026; ~16-18 months after intervention start) or term 2 (cold season, May-July 2026; ~20-22 months). Data reported across both rounds.

As for the all-episodes duration outcome, restricted to episodes classified as serious.

A serious illness episode is one during which a child's ill-health symptoms are severe enough to require medical care, either immediately or the next day. This classification is based on WHO tools (c-IMCI and IMAI): Care is needed when (i) a child experiences any red-flag symptom (e.g. difficulty breathing, convulsions); (ii) has symptoms suggestive of certain conditions (e.g. measles, malaria); (iii) has experienced mild symptoms for a long time (coughing for 14 days, etc).

Mean consecutive symptom-days per serious episode, estimated from the same discrete-time hazard model, with ongoing episodes contributing observed (censored) days and day-1 episodes excluded as left-truncated. Reported as a restricted mean over the eight-week window.

Eight-week daily health-diary window, completed once per child in either term 1 (rainy season, January-March 2026; ~16-18 months after intervention start) or term 2 (cold season, May-July 2026; ~20-22 months). Data reported across both rounds.
Menstrual health practices
Tidsramme: Endline, May-July 2026 (approximately 20-22 months after the start of the intervention, September 2024). Single assessment.
Share of responses indicating good menstrual management across the practices items. Item set is the final 5 items pilot-retained from a pre-specified pool adapted from the same validated instruments. Computed per respondent as (good-management responses) / (items answered), averaged across girls who have reached menarche in the sub-sample. Higher values indicate better practices.
Endline, May-July 2026 (approximately 20-22 months after the start of the intervention, September 2024). Single assessment.
Menstrual health stigma index
Tidsramme: Endline, May-July 2026 (approximately 20-22 months after the start of the intervention, September 2024). Single assessment.
First principal component of a PCA over the menstrual health stigma items (final 4 items pilot-retained from a pre-specified pool adapted from the same validated instruments; construction rule fixed prior to piloting). Loadings estimated on the pooled sample; scores standardised to the control-group mean and standard deviation. Oriented so that higher values indicate lesser stigma; a beneficial programme effect corresponds to a reduction. Constructed for girls grade 5 or above who have heard of menstruation.
Endline, May-July 2026 (approximately 20-22 months after the start of the intervention, September 2024). Single assessment.
Learning - Literacy
Tidsramme: Endline, May-July 2026 (approximately 20-22 months after the start of the intervention, September 2024). Single assessment.
Item-response-theory (IRT) ability score in literacy, estimated over per-item responses from the grade-banded exam blocks (lower-, middle-, and upper-grade versions) placed on a common within-domain scale via shared anchor items. Standardised to the control-group mean and standard deviation. Higher values indicate greater literacy ability.
Endline, May-July 2026 (approximately 20-22 months after the start of the intervention, September 2024). Single assessment.
Learning - Numeracy
Tidsramme: Endline, May-July 2026 (approximately 20-22 months after the start of the intervention, September 2024). Single assessment.
IRT ability score in numeracy, estimated over per-item responses from the grade-banded exam blocks (lower-, middle-, upper-grade versions) linked to a common within-domain scale via shared anchor items. Standardised to the control-group mean and SD. Higher values indicate greater numeracy ability.
Endline, May-July 2026 (approximately 20-22 months after the start of the intervention, September 2024). Single assessment.
Learning - Science and Health
Tidsramme: Endline, May-July 2026 (approximately 20-22 months after the start of the intervention, September 2024). Single assessment.
IRT ability score in science and health knowledge, estimated over per-item responses from the grade-banded exam blocks (lower-, middle-, upper-grade versions) linked to a common within-domain scale via shared anchor items. Standardised to the control-group mean and SD. Higher values indicate greater ability.
Endline, May-July 2026 (approximately 20-22 months after the start of the intervention, September 2024). Single assessment.
Learning - overall
Tidsramme: Endline, May-July 2026 (approximately 20-22 months after the start of the intervention, September 2024). Single assessment.
Composite learning score, defined as the mean of the three control-standardised domain scores (literacy, numeracy, science), each an IRT ability score placed on a common within-domain scale across grade bands via anchor items and standardised to the control-group mean and SD. Domains enter with equal weight. Higher values indicate greater overall learning ability.
Endline, May-July 2026 (approximately 20-22 months after the start of the intervention, September 2024). Single assessment.
Students' working memory and attention
Tidsramme: Endline, May-July 2026 (approximately 20-22 months after the start of the intervention, September 2024). Single assessment.
Students' working memory and attention is measured using the Digit Span task, a widely used short-term memory and working memory assessment. Enumerators orally present a sequence of digits at a rate of one per second, and students are asked to repeat the digits in the same order (Digit Span Forward) and then in reverse order (Digit Span Backward). The task measures students' auditory attention, concentration, and working memory capacity, which are foundational components of general cognitive functioning and predictive of academic achievement. Scores are recorded as the total number of correct sequences reproduced, following standard administration and scoring procedures.
Endline, May-July 2026 (approximately 20-22 months after the start of the intervention, September 2024). Single assessment.
Combined measure of attendance and retention
Tidsramme: Repeated measure captured at each of five unannounced attendance spot checks: term 1 2025, term 2 2025, term 3 2025, term 1 2026, and term 2 2026 (alongside endline), approximately 4-22 months after the start of the intervention (September 2024)
Proportion of children confirmed present in class on the day of the visit, out of the total number of children enrolled at the school at baseline and still alive. This measure effectively treats children who may have transferred to another study school as 'absent', dropped out, or temporarily relocated.
Repeated measure captured at each of five unannounced attendance spot checks: term 1 2025, term 2 2025, term 3 2025, term 1 2026, and term 2 2026 (alongside endline), approximately 4-22 months after the start of the intervention (September 2024)
Attendance rate including learners transfered to other study schools
Tidsramme: Repeated measure captured at each of five unannounced attendance spot checks: term 1 2025, term 2 2025, term 3 2025, term 1 2026, and term 2 2026 (alongside endline), approximately 4-22 months after the start of the intervention (September 2024)
Proportion of children confirmed present in class on the day of the visit either in their original school or in another school to which they have transferred if that school is one of the study schools, out of the total number of children enrolled at baseline and still alive. Analysis will follow Intention-to-Treat principle, treating participants as assigned to their original treatment arm, even if they moved to a different study arm school.
Repeated measure captured at each of five unannounced attendance spot checks: term 1 2025, term 2 2025, term 3 2025, term 1 2026, and term 2 2026 (alongside endline), approximately 4-22 months after the start of the intervention (September 2024)
Illness- or menstruation-related absence
Tidsramme: Eight-week daily health-diary window, completed once per child in either term 1 (rainy season, January-March 2026; ~16-18 months after intervention start) or term 2 (cold season, May-July 2026; ~20-22 months). Data reported across both rounds.
From the diary's daily records, caregivers flag whether the child attended school each day and records the reason for each absent day. The reasons are: illness (1), was menstruating (2), farming (3), school closure or school event (4), bad weather (5), religious reasons (6), market day (7), public holiday (8), fishing (9), mining (10), working with parents (11), no uniform/shoes/books (12), and other (-97). A day missed is considered caused by an illness or menstruation-related absence when the reason is (1) or (2). The sample is restricted to school days by dropping weekends and public holidays. This measure is the share of the child's school days in the diary window lost to health-related absence: health-related absence days divided by total school days observed.
Eight-week daily health-diary window, completed once per child in either term 1 (rainy season, January-March 2026; ~16-18 months after intervention start) or term 2 (cold season, May-July 2026; ~20-22 months). Data reported across both rounds.
Menstrual health knowledge
Tidsramme: Endline, May-July 2026 (approximately 20-22 months after the start of the intervention, September 2024). Single assessment.
Share of correct responses across three menstrual health knowledge items. The item set is the final items retained after in-country piloting for comprehension and relevance, from a pre-specified pool adapted from validated instruments. Computed per respondent as (correct responses) / (items answered), averaged within the relevant sub-sample: girls grade 5 or above who have heard of menstruation. Higher values indicate greater knowledge.
Endline, May-July 2026 (approximately 20-22 months after the start of the intervention, September 2024). Single assessment.

Andre resultatmål

Resultatmål
Tiltaksbeskrivelse
Tidsramme
Boys' menstrual health knowledge
Tidsramme: Endline, May-July 2026 (approximately 20-22 months after the start of the intervention, September 2024). Single assessment.
Menstrual health knowledge index (share of correct responses), constructed identically to the girls' secondary-outcome knowledge - same item set and same (correct responses) / (items answered) construction - on the sample of boys who have heard of menstruation. Higher values indicate greater knowledge. Parallels the girls' secondary outcome to assess whether the programme shifts boys' menstrual knowledge.
Endline, May-July 2026 (approximately 20-22 months after the start of the intervention, September 2024). Single assessment.
Boys' menstrual health stigma
Tidsramme: Endline, May-July 2026 (approximately 20-22 months after the start of the intervention, September 2024). Single assessment.

Menstrual health stigma index, constructed identically to the girls' secondary-outcome stigma index - first principal component of a PCA over the same stigma items - on the sample of boys who have heard of menstruation. Standardised to the boys' control-group mean and standard deviation; oriented so that higher values indicate lesser stigma, consistent with the girls' index.

Parallels the girls' secondary outcome to assess whether the programme shifts boys' menstrual stigma.

Endline, May-July 2026 (approximately 20-22 months after the start of the intervention, September 2024). Single assessment.
School environment and belonging
Tidsramme: Endline, May-July 2026 (approximately 20-22 months after the start of the intervention, September 2024). Single assessment.
Measured using a short school belonging and climate scale drawn from the Young Lives study, designed to capture children's subjective experiences of school in a simple, age-appropriate way. The tool focuses on core dimensions of belonging-enjoyment, perceived care from teachers and peers, safety, respect, and mutual support-using a consistent three-point response scale ("No, almost never", "Sometimes", "Yes, almost always"). Its brevity makes it suitable for large surveys with primary-school children while still capturing meaningful variation in how supported and included students feel in their school environment. To analyse responses, investigators will construct a simple index using principal component analysis, normalising on the control group for ease of interpretation.
Endline, May-July 2026 (approximately 20-22 months after the start of the intervention, September 2024). Single assessment.
Children's emotional well-being at school
Tidsramme: Endline, May-July 2026 (approximately 20-22 months after the start of the intervention, September 2024). Single assessment.
Using the child well-being at school scale developed by the Young Lives study to capture children's emotional experiences while at school in a simple and age-appropriate way. The tool focuses on both positive and negative affective states-see appendix-and uses a consistent three-point response scale ("No, almost never", "Sometimes", "Yes, almost always"). Its simplicity makes it suitable for administration to primary school children. To analyse responses, investigators will construct a simple index using principal component analysis, normalising on the control group for ease of interpretation.
Endline, May-July 2026 (approximately 20-22 months after the start of the intervention, September 2024). Single assessment.
Learner-reported teacher engagement and conduct
Tidsramme: Endline, May-July 2026 (approximately 20-22 months after the start of the intervention, September 2024). Single assessment.
A PCA index z-scored on the control group from the learner survey, combining a conduct checklist (teacher late, absent, or on their phone) with a 5-point Likert engagement battery (teacher cares, makes lessons interesting, offers extra help, motivates), oriented so a higher score is better conduct and engagement
Endline, May-July 2026 (approximately 20-22 months after the start of the intervention, September 2024). Single assessment.
Any Bullying
Tidsramme: Endline, May-July 2026 (approximately 20-22 months after the start of the intervention, September 2024). Single assessment.
Indicator equal to 1 if child responds yes to any bullying item, from a five item yes/no checklist of acts experienced in the last week attended (mean names, threats, physical harm, exclusion, lies).
Endline, May-July 2026 (approximately 20-22 months after the start of the intervention, September 2024). Single assessment.
Bullying count
Tidsramme: Endline, May-July 2026 (approximately 20-22 months after the start of the intervention, September 2024). Single assessment.
Count of acts of bullying, when child responds yes to any bullying item, from a five item yes/no checklist of acts experienced in the last week attended (mean names, threats, physical harm, exclusion, lies).
Endline, May-July 2026 (approximately 20-22 months after the start of the intervention, September 2024). Single assessment.
Corporal punishment
Tidsramme: Endline, May-July 2026 (approximately 20-22 months after the start of the intervention, September 2024). Single assessment.
From a parallel yes/no checklist of acts a teacher used on the child in the past month, spanning verbal (shouting) and escalating physical acts. The primary measure is an indicator for any act and the secondary measures are the count of distinct acts and a physical-punishment indicator restricted to the acts involving physical contact.
Endline, May-July 2026 (approximately 20-22 months after the start of the intervention, September 2024). Single assessment.
Corporal punishment acceptance norms
Tidsramme: Endline, May-July 2026 (approximately 20-22 months after the start of the intervention, September 2024). Single assessment.
Acceptance of corporal punishment, elicited via a teacher discipline vignette (respondents hear a scenario and rate the depicted teacher's reaction). Standardised-mean acceptance-norms index over four items: (i) own acceptability of the reaction; (ii) injunctive social norm - number of five colleagues expected to find it acceptable (0-5); (iii) descriptive social norm - number of five colleagues expected to react likewise (0-5); (iv) own behavioural attitude - self-rated likelihood of acting the same way. Each item is oriented so that higher indicates greater acceptance and standardised to the control-group mean and SD before averaging (standardisation places the differing item scales on a common metric). Higher index values indicate greater acceptance of corporal punishment.
Endline, May-July 2026 (approximately 20-22 months after the start of the intervention, September 2024). Single assessment.
Teacher job satisfaction
Tidsramme: Endline, May-July 2026 (approximately 20-22 months after the start of the intervention, September 2024). Single assessment.
Teacher-reported job satisfaction, summarised across the eight satisfaction items (teacher satisfaction 1-8) as standardised-mean index. Higher values indicate greater satisfaction. Teacher-level.
Endline, May-July 2026 (approximately 20-22 months after the start of the intervention, September 2024). Single assessment.
Teacher burnout
Tidsramme: Endline, May-July 2026 (approximately 20-22 months after the start of the intervention, September 2024). Single assessment.
Emotional-exhaustion subscale of the Maslach Burnout Inventory, the primary burnout indicator, summarised as subscale mean. Higher values indicate greater exhaustion.
Endline, May-July 2026 (approximately 20-22 months after the start of the intervention, September 2024). Single assessment.
Teacher turnover intention
Tidsramme: Endline, May-July 2026 (approximately 20-22 months after the start of the intervention, September 2024). Single assessment.
Indicator = 1 if the teacher reports intending to leave teaching at the point of the survey. All endline-surveyed teachers. Higher = greater intent to leave.
Endline, May-July 2026 (approximately 20-22 months after the start of the intervention, September 2024). Single assessment.
Realised teacher turnover
Tidsramme: Baseline to endline: teacher's school-presence status at endline (May-July 2026) relative to their originally sampled school at baseline ([baseline month/year]); interval of approximately 24-26 months.
Indicator = 1 if a teacher randomly sampled at baseline is no longer at their original school at endline (whether they left teaching or moved schools), from tracking of the baseline-sampled cohort rather than the endline survey. Population differs from the survey-based teacher outcomes; measures change over the baseline-to-endline interval. Time Frame: Unit: proportion.
Baseline to endline: teacher's school-presence status at endline (May-July 2026) relative to their originally sampled school at baseline ([baseline month/year]); interval of approximately 24-26 months.
Teacher locus of control
Tidsramme: Endline, May-July 2026 (approximately 20-22 months after the start of the intervention, September 2024). Single assessment.

Locus-of-control index over four items:

  1. "There is little I can do to help a student's learning."
  2. "Pupils come unprepared from previous grades."
  3. "Parents do not have the necessary education to help their child be more successful at school."
  4. "If parents would do more for their children, I could do more." where respondents answer "agree" or "disagree". Summarised as standardised-mean index, oriented so that higher values indicate more locus of control.
Endline, May-July 2026 (approximately 20-22 months after the start of the intervention, September 2024). Single assessment.
Teacher time use - health-related duties
Tidsramme: Endline, May-July 2026 (approximately 20-22 months after the start of the intervention, September 2024). Single assessment.
Self-reported hours in a typical day spent on health-related programmes in the school, from the teacher time-use module (recall over four mutually exclusive categories: teaching/instructing; planning and grading; health-related programmes; other school responsibilities). Primary time-use quantity; the mechanism-relevant category for a school-health intervention.
Endline, May-July 2026 (approximately 20-22 months after the start of the intervention, September 2024). Single assessment.
Teacher time use - teaching/instruction
Tidsramme: Endline, May-July 2026 (approximately 20-22 months after the start of the intervention, September 2024). Single assessment.
Self-reported hours in a typical day spent teaching/instructing, from the teacher time-use module (recall over four mutually exclusive categories: teaching/instructing; planning and grading; health-related programmes; other school responsibilities). Reported alongside health-duty time to capture reallocation away from core instruction.
Endline, May-July 2026 (approximately 20-22 months after the start of the intervention, September 2024). Single assessment.
Anthropometry - stunting prevalence
Tidsramme: Endline, May-July 2026 (approximately 20-22 months after the start of the intervention, September 2024). Single assessment.
Prevalence of stunting (chronic undernutrition) among children measured at endline. A child is classified stunted if their height-for-age z-score (HAZ) is more than 2 SD below the reference median, using the WHO Growth Reference for school-aged children and adolescents (de Onis et al. 2007; ages 5-19, sex-specific), with z-scores computed from completed age in months at the date of measurement. HAZ values outside -6 to +6 are treated as biologically implausible and excluded per WHO flagging conventions; the number of excluded observations is reported.
Endline, May-July 2026 (approximately 20-22 months after the start of the intervention, September 2024). Single assessment.
Any anaemia
Tidsramme: Single biomarker measurement at the end of the child's diary round - term 1 (~March 2026; ~18 months after intervention start) or term 2 (~July 2026; ~22 months). Data reported across both rounds.
Using the same haemoglobin measurements collected during the biomarker survey (hbg result, in g/dL), investigators will construct the proportion of children suffering from any anaemia (mild, moderate or severe), using WHO thresholds: A child is classified as anaemic if adjusted haemoglobin falls below 11.5 g/dL at ages 5 to 11, below 12.0 g/dL at ages 12 to 14, below 12.0 g/dL for non-pregnant females aged 15 and above, and below 13.0 g/dL for males aged 15 and above, with age taken at the date of the biomarker round.
Single biomarker measurement at the end of the child's diary round - term 1 (~March 2026; ~18 months after intervention start) or term 2 (~July 2026; ~22 months). Data reported across both rounds.
Malaria - untreated infection prevalence
Tidsramme: Single biomarker measurement at the end of the child's diary round - term 1 (~March 2026; ~18 months after intervention start) or term 2 (~July 2026; ~22 months). Data reported across both rounds.
Indicator = 1 if a child in the biomarker sample tests positive for malaria and has no treatment recorded in their diary in the past 4 weeks; 0 otherwise, including test-negative children. Defined over all children tested, so the estimate does not condition on infection status. Because this joint indicator reflects both infection prevalence and treatment coverage, it is interpreted as descriptive/mechanistic and read alongside overall infection prevalence, not as a standalone treatment-gap contrast.
Single biomarker measurement at the end of the child's diary round - term 1 (~March 2026; ~18 months after intervention start) or term 2 (~July 2026; ~22 months). Data reported across both rounds.
Malaria - asymptomatic infection prevalence
Tidsramme: Single biomarker measurement at the end of the child's diary round - term 1 (~March 2026; ~18 months after intervention start) or term 2 (~July 2026; ~22 months). Data reported across both rounds.
Indicator = 1 if a child tests positive and reports no malaria-suggestive symptom (fever, headache, vomiting, lethargy) at the time of the test or in the four preceding days; 0 otherwise, including negatives. Over all children tested; no conditioning on infection status. Descriptive/mechanistic; read alongside overall prevalence.
Single biomarker measurement at the end of the child's diary round - term 1 (~March 2026; ~18 months after intervention start) or term 2 (~July 2026; ~22 months). Data reported across both rounds.
Parental health knowledge
Tidsramme: Endline, May-July 2026 (approximately 20-22 months after the start of the intervention, September 2024). Single assessment.
Share of correct answers on a health-knowledge battery (HN01, HN04, HHK1, HHK2, DS10, HN05) covering nutrition, hygiene, and specific child illnesses. Responses will be scored as correct or incorrect, with "don't know" treated as incorrect, and summed into an additive index.
Endline, May-July 2026 (approximately 20-22 months after the start of the intervention, September 2024). Single assessment.
Parental relative trust in the school health room (vs government clinic)
Tidsramme: Endline, May-July 2026 (approximately 20-22 months after the start of the intervention, September 2024). Single assessment.
Relative expected provider quality for the school health room versus the government clinic, from a paired quality-expectation vignette: respondents estimate, for the same 10 hypothetical febrile children, how many would receive a correct diagnosis and how many a full supply of correct treatment at each provider (0-10 each). Relative-trust index = the school-health-room minus government-clinic expectation, averaged across the diagnosis and treatment items (equivalently, the mean of the two paired differences). Positive values indicate greater expected quality at the school health room.
Endline, May-July 2026 (approximately 20-22 months after the start of the intervention, September 2024). Single assessment.
Willingness to pay for school health programme
Tidsramme: Endline, May-July 2026 (approximately 20-22 months after the start of the intervention, September 2024). Single assessment.
From a takeit-or-leave-it elicitation in which each guardian is offered a randomly assigned annual fee for the school health room [10, 20, 30, 40 or 50 Kwacha - 30 is the real marginal cost of the programme] and states whether they would pay it. For the control group, the same elicitation takes place but the programme description is hypothetical. The willingness to pay measure is the indicator for accepting the offered price.
Endline, May-July 2026 (approximately 20-22 months after the start of the intervention, September 2024). Single assessment.
Anthropometry - thinness prevalence
Tidsramme: Endline, May-July 2026 (approximately 20-22 months after the start of the intervention, September 2024). Single assessment.
Prevalence of thinness (acute undernutrition; the WHO term for this age group) among children measured at endline. A child is classified thin if their BMI-for-age z-score (BAZ) is more than 2 SD below the reference median, using the same WHO reference. BMI-for-age is used rather than weight-for-age, which is confounded by stunting; BMI-for-age standardises weight against the child's own height. BAZ values outside -5 to +5 are excluded as biologically implausible per WHO flagging; the number excluded is reported.
Endline, May-July 2026 (approximately 20-22 months after the start of the intervention, September 2024). Single assessment.

Samarbeidspartnere og etterforskere

Det er her du vil finne personer og organisasjoner som er involvert i denne studien.

Etterforskere

  • Hovedetterforsker: Mylene Lagarde, PhD, London School of Economics and Political Science
  • Studiestol: David Ross, PhD, University of Stellenbosch

Studierekorddatoer

Disse datoene sporer fremdriften for innsending av studieposter og sammendragsresultater til ClinicalTrials.gov. Studieposter og rapporterte resultater gjennomgås av National Library of Medicine (NLM) for å sikre at de oppfyller spesifikke kvalitetskontrollstandarder før de legges ut på det offentlige nettstedet.

Studer hoveddatoer

Studiestart (Faktiske)

27. februar 2024

Primær fullføring (Faktiske)

15. juli 2026

Studiet fullført (Antatt)

31. desember 2026

Datoer for studieregistrering

Først innsendt

12. august 2024

Først innsendt som oppfylte QC-kriteriene

15. august 2024

Først lagt ut (Faktiske)

19. august 2024

Oppdateringer av studieposter

Sist oppdatering lagt ut (Faktiske)

27. august 2026

Siste oppdatering sendt inn som oppfylte QC-kriteriene

25. august 2026

Sist bekreftet

1. juli 2026

Mer informasjon

Begreper knyttet til denne studien

Plan for individuelle deltakerdata (IPD)

Planlegger du å dele individuelle deltakerdata (IPD)?

JA

IPD-planbeskrivelse

Etterforskerne vil dele et komplett datasett på individnivå som inneholder alle primære og sekundære studieresultater, eventuelle andre variabler brukt i analysen og behandlingsoppdrag. Data vil bli anonymisert for å sikre at ingen deltakere kan identifiseres personlig (direkte eller indirekte)

IPD-delingstidsramme

Data vil være tilgjengelig permanent. De vil bli tilgjengelige sammen med publisering av studien i et tidsskrift, ettersom vi vil gi en replikeringspakke som en del av publikasjonen.

IPD-deling Støtteinformasjonstype

  • STUDY_PROTOCOL
  • SEVJE
  • ICF
  • ANALYTIC_CODE

Legemiddel- og utstyrsinformasjon, studiedokumenter

Studerer et amerikansk FDA-regulert medikamentprodukt

Nei

Studerer et amerikansk FDA-regulert enhetsprodukt

Nei

Denne informasjonen ble hentet direkte fra nettstedet clinicaltrials.gov uten noen endringer. Hvis du har noen forespørsler om å endre, fjerne eller oppdatere studiedetaljene dine, vennligst kontakt register@clinicaltrials.gov. Så snart en endring er implementert på clinicaltrials.gov, vil denne også bli oppdatert automatisk på nettstedet vårt. .

Abonnere